- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 174-188 of
901 results
1042 Exhibit: 1042 WO 9111457
Document
IPR2024-00631, No. 1042 Exhibit - 1042 WO 9111457 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1068 Exhibit: 1068 US Patent No 8,129,343
Document
IPR2024-00631, No. 1068 Exhibit - 1068 US Patent No 8,129,343 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1026 Exhibit: 1026 HARRISON’S PRINCIPLES OF INTERNAL MED, Chapter 338 F...
Document
IPR2024-00631, No. 1026 Exhibit - 1026 HARRISON’S PRINCIPLES OF INTERNAL MED, Chapter 338 Fauci et al eds (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1075 Exhibit: 1075 US Patent No 7,022,674
Document
IPR2024-00631, No. 1075 Exhibit - 1075 US Patent No 7,022,674 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1084 Exhibit: 1084 EMA, ICH Topic S 7 A Safety Pharmacology Studies for Human ...
Document
IPR2024-00631, No. 1084 Exhibit - 1084 EMA, ICH Topic S 7 A Safety Pharmacology Studies for Human Pharmaceuti (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1019 Exhibit: 1019 Bell, Hamster Preproglucagon Contains the Sequence of Gluca...
Document
IPR2024-00631, No. 1019 Exhibit - 1019 Bell, Hamster Preproglucagon Contains the Sequence of Glucagon and Two (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1031 Exhibit: 1031 Knudsen, GLP1 Derivatives as Novel Compounds for the Treat...
Document
IPR2024-00631, No. 1031 Exhibit - 1031 Knudsen, GLP1 Derivatives as Novel Compounds for the Treatment of Typ (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1027 Exhibit: 1027 Holst, Truncated Glucagon like Peptide I, an Insulin Releasing H...
Document
IPR2024-00631, No. 1027 Exhibit - 1027 Holst, Truncated Glucagon like Peptide I, an Insulin Releasing Hormone (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1038 Exhibit: 1038 Seino, Dose Dependent Improvement in Glycemia with Once Da...
Document
IPR2024-00631, No. 1038 Exhibit - 1038 Seino, Dose Dependent Improvement in Glycemia with Once Daily Liraglut (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1051 Exhibit: 1051 Landersdorfer, PharmacokineticPharmacodynamic Modelling in...
Document
IPR2024-00631, No. 1051 Exhibit - 1051 Landersdorfer, PharmacokineticPharmacodynamic Modelling in Diabetes M (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
2533 Exhibit: EX2533 Declaration of Jenny C Wu
Document
IPR2023-00724, No. 2533 Exhibit - EX2533 Declaration of Jenny C Wu (P.T.A.B. Mar. 6, 2024)
|
|
Cite Document
2534 Exhibit: EX2534 Declaration of Philip S May
Document
IPR2023-00724, No. 2534 Exhibit - EX2534 Declaration of Philip S May (P.T.A.B. Mar. 6, 2024)
|
|
Cite Document
2110 Exhibit: EX2110 Verges, B and Charbonnel, B, After the LEADER trial and SU...
Document
IPR2023-00724, No. 2110 Exhibit - EX2110 Verges, B and Charbonnel, B, After the LEADER trial and SUSTAIN 6, how do we explain the cardiovascular benefits of some GLP 1 receptor agonis...
|
|
Cite Document
2086 Exhibit: EX2086 Abdul Ghani, M, et al, Cardiovascular Disease and Type 2 Di...
Document
IPR2023-00724, No. 2086 Exhibit - EX2086 Abdul Ghani, M, et al, Cardiovascular Disease and Type 2 Diabetes Has the Dawn of a New Era Arrived, Diabetes Care, 40813 820 2017 (P.T.A.B. Ja...
|
|
Cite Document
2515 Exhibit: EX2515 Novo Nordisk, Financial report for the period 1 January 2023...
Document
IPR2023-00724, No. 2515 Exhibit - EX2515 Novo Nordisk, Financial report for the period 1 January 2023 to 30 June 2023 Aug 10, 2023 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
